Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A07537 | 32451205 | Ann Hepatol | Is there an association between commonly employed biomarkers of liver fibrosis and liver stiffness in the general population? | 2020 | Details |
| A07538 | 32451200 | Arab J Gastroenterol | The roles and interaction of FXR and PPARs in the pathogenesis of nonalcoholic fatty liver disease. | 2020 | Details |
| A07539 | 32450865 | Lipids Health Dis | Long term N-acetylcysteine administration rescues liver steatosis via endoplasmic reticulum stress with unfolded protein response in mice. | 2020 | Details |
| A07540 | 32450460 | Prostaglandins Leukot Essent Fatty Acids | Omega-3 derivatives, specialized pro-resolving mediators: Promising therapeutic tools for the treatment of pain in chronic liver disease. | 2020 | Details |
| A07541 | 32450363 | Clin Gastroenterol Hepatol | Accuracy of Two-Dimensional Shear Wave Elastography and Attenuation Imaging for Evaluation of Patients With Nonalcoholic Steatohepatitis. | 2020 | Details |
| A07542 | 32450149 | Gastroenterology | Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122. | 2020 | Details |
| A07543 | 32448832 | Intern Med | SGLT2 Inhibitor Treatment Outcome in Nonalcoholic Fatty Liver Disease Complicated with Diabetes Mellitus: The Long-term Effects on Clinical Features and Liver Histopathology. | 2020 | Details |
| A07544 | 32448788 | BMJ Open Diabetes Res Care | Effects of a multifactorial ecosustainable isocaloric diet on liver fat in patients with type 2 diabetes: randomized clinical trial. | 2020 | Details |
| A07545 | 32448495 | Am J Med Sci | Nonalcoholic Fatty Liver Disease Associated With Bladder Cancer. | 2020 | Details |
| A07546 | 32447913 | Zhonghua Liu Xing Bing Xue Za Zhi | [Association between tooth missing and non-alcoholic fatty liver disease]. | 2020 | Details |
| A07547 | 32447878 | Clin Mol Hepatol | Clinical application of ultrasonography-guided percutaneous liver biopsy and its safety over 18 years. | 2020 | Details |
| A07548 | 32446270 | Br J Pharmacol | Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non-alcoholic fatty liver disease by up-regulating the FGF21/PGC-1α pathway. | 2020 | Details |
| A07549 | 32446022 | Semin Arthritis Rheum | Safety of TNF inhibitors in rheumatic disease in case of NAFLD and cirrhosis. | 2020 | Details |
| A07551 | 32445755 | Toxicol Appl Pharmacol | PBPK modeling of impact of nonalcoholic fatty liver disease on toxicokinetics of perchloroethylene in mice. | 2020 | Details |
| A07552 | 32445754 | Toxicol Appl Pharmacol | Adipose tissue-liver crosstalk during pathologic changes caused by vinyl chloride metabolites in mice. | 2020 | Details |
| A07555 | 32444690 | Sci Rep | Histological grading evaluation of non-alcoholic fatty liver disease after bariatric surgery: a retrospective and longitudinal observational cohort study. | 2020 | Details |
| A07556 | 32444289 | Semin Cell Dev Biol | Hepatic lipid droplet homeostasis and fatty liver disease. | 2020 | Details |
| A07557 | 32444241 | Clin Nutr | Medium term post-bariatric surgery deficit of vitamin B12 is predicted by deficit at time of surgery. | 2020 | Details |
| A07558 | 32443971 | Hereditas | Relationship between circulating miR-132 and non-alcoholic fatty liver disease in a Chinese population. | 2020 | Details |
| A07559 | 32443660 | Nutrients | Gallic Acid Inhibits Lipid Accumulation via AMPK Pathway and Suppresses Apoptosis and Macrophage-Mediated Inflammation in Hepatocytes. | 2020 | Details |
| A07560 | 32443556 | Nutrients | Bromelain Confers Protection against the Non-Alcoholic Fatty Liver Disease in Male C57bl/6 Mice. | 2020 | Details |
| A07561 | 32443539 | Int J Mol Sci | Genetic Susceptibility to Chronic Liver Disease in Individuals from Pakistan. | 2020 | Details |
| A07562 | 32443453 | Int J Environ Res Public Health | Utility of Liver Function Tests and Fatty Liver Index to Categorize Metabolic Phenotypes in a Mediterranean Population. | 2020 | Details |
| A07564 | 32442908 | Cytokine | Gastric banding-associated weight loss diminishes hepatic Tsukushi expression. | 2020 | Details |
| A07565 | 32442221 | PLoS One | Expression of hepatic stellate cell activation-related genes in HBV-, HCV-, and nonalcoholic fatty liver disease-associated fibrosis. | 2020 | Details |
| A07566 | 32440840 | J Nephrol | Therapeutic implications of shared mechanisms in non-alcoholic fatty liver disease and chronic kidney disease. | 2020 | Details |
| A07567 | 32440746 | Dig Dis Sci | Validation of the Expanded Baveno-VI Criteria for Screening Gastroscopy in Asian Patients with Compensated Advanced Chronic Liver Disease. | 2020 | Details |
| A07569 | 32440680 | Inflamm Bowel Dis | Multidimensional Impact of Mediterranean Diet on IBD Patients. | 2021 | Details |
| A07570 | 32440483 | Adv Sci (Weinh) | Hepatocyte TMEM16A Deletion Retards NAFLD Progression by Ameliorating Hepatic Glucose Metabolic Disorder. | 2020 | Details |
| A07571 | 32440372 | PeerJ | Nonalcoholic fatty liver disease, a potential risk factor of non-specific ST-T segment changes: data from a cross-sectional study. | 2020 | Details |
| A07572 | 32440112 | Int J Chron Obstruct Pulmon Dis | Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008-2011). | 2020 | Details |
| A07573 | 32439605 | Drug Discov Today | Long noncoding RNAs in nonalcoholic fatty liver disease and liver fibrosis: state-of-the-art and perspectives in diagnosis and treatment. | 2020 | Details |
| A07574 | 32439267 | Clin Nutr | Theaphenon E prevents fatty liver disease and increases CD4+ T cell survival in mice fed a high-fat diet. | 2020 | Details |
| A07575 | 32438959 | Biomed Environ Sci | Peripheral Artery Disease and Risk of Fibrosis Deterioration in Nonalcoholic Fatty Liver Disease: A Prospective Investigation. | 2020 | Details |
| A07576 | 32438122 | J Nutr Biochem | Resveratrol prevents liver damage in MCD-induced steatohepatitis mice by promoting SIGIRR gene transcription. | 2020 | Details |
| A07577 | 32437795 | Life Sci | TLR4 knockout upregulates the expression of Mfn2 and PGC-1α in a high-fat diet and ischemia-reperfusion mice model of liver injury. | 2020 | Details |
| A07578 | 32437790 | Life Sci | Ginsenoside Rg1 protects against d-galactose induced fatty liver disease in a mouse model via FOXO1 transcriptional factor. | 2020 | Details |
| A07579 | 32437208 | Bratisl Lek Listy | Non-alcoholic fatty liver disease increases the prevalence of maintenance haemodialysis in patients with chronic kidney disease. | 2020 | Details |
| A07580 | 32436818 | Curr Pharm Des | The Relevance of Noninvasive Tools To Assess Fibrosis in Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A07581 | 32436410 | Nutr Cancer | Combined Amelioration of Prebiotic Resveratrol and Probiotic Bifidobacteria on Obesity and Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07582 | 32436128 | High Blood Press Cardiovasc Prev | Evaluation of Cardiovascular Risk in Patient with Primary Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A07583 | 32435754 | JHEP Rep | Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosis. | 2020 | Details |
| A07584 | 32435522 | World J Gastrointest Pathophysiol | Non-alcoholic fatty liver disease and Atherosclerosis at a crossroad: The overlap of a theory of change and bioinformatics. | 2020 | Details |
| A07585 | 32435130 | Microbiol Insights | Presence of Hepatic Steatosis Does Not Increase the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Over Long Follow-Up. | 2020 | Details |
| A07586 | 32434740 | Transplant Proc | The Utility of Assessing Liver Allograft Fibrosis and Steatosis Post-Liver Transplantation Using Transient Elastography With Controlled Attenuation Parameter. | 2020 | Details |
| A07587 | 32434704 | Clin Res Hepatol Gastroenterol | The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study. | 2020 | Details |
| A07588 | 32434697 | Transl Res | Cathepsin B deficiency ameliorates liver lipid deposition, inflammatory cell infiltration, and fibrosis after diet-induced nonalcoholic steatohepatitis. | 2020 | Details |
| A07589 | 32433419 | Eur J Gastroenterol Hepatol | Low real-world eligibility rates for nonalcoholic steatohepatitis patients for phase 3 clinical trial criteria application in a large academic health system. | 2021 | Details |
| A07590 | 32432822 | Liver Int | Hypoxia-inducible factor 2α drives hepatosteatosis through the fatty acid translocase CD36. | 2020 | Details |
| A07591 | 32432142 | World J Clin Cases | Cholesteryl ester storage disease of clinical and genetic characterisation: A case report and review of literature. | 2020 | Details |
| A07592 | 32431529 | Diabetes Metab Syndr Obes | Changes in Serum Nesfatin-1 After Laparoscopic Sleeve Gastrectomy are Associated with Improvements in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07593 | 32431528 | Diabetes Metab Syndr Obes | Association Between Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome with Gallstone Disease, South Iran: A Population-Based Study. | 2020 | Details |
| A07594 | 32431136 | J Clin Res Pediatr Endocrinol | Different Potent Glucocorticoids, Different Routes of Exposure but the Same Result: Iatrogenic Cushing’s Syndrome and Adrenal Insufficiency | 2020 | Details |
| A07595 | 32431115 | Diabetes Metab J | Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association. | 2020 | Details |
| A07596 | 32430018 | Lipids Health Dis | Chia (Salvia hispanica)-supplemented diet ameliorates non-alcoholic fatty liver disease and its metabolic abnormalities in humans. | 2020 | Details |
| A07597 | 32429849 | BMC Immunol | Anti-inflammatory activity of berberine in non-alcoholic fatty liver disease via the Angptl2 pathway. | 2020 | Details |
| A07598 | 32429653 | Pol J Pathol | Role of mast cells in the pathogenesis of liver fibrosis in nonalcoholic fatty liver disease. | 2020 | Details |
| A07599 | 32429590 | Nutrients | Changed Amino Acids in NAFLD and Liver Fibrosis: A Large Cross-Sectional Study without Influence of Insulin Resistance. | 2020 | Details |
| A07600 | 32429478 | Cells | Exogenous Liposomal Ceramide-C6 Ameliorates Lipidomic Profile, Energy Homeostasis, and Anti-Oxidant Systems in NASH. | 2020 | Details |
| A07601 | 32429274 | Nutrients | The Protective Effect of Cynara Cardunculus Extract in Diet-Induced NAFLD: Involvement of OCTN1 and OCTN2 Transporter Subfamily. | 2020 | Details |
| A07602 | 32428560 | Biochim Biophys Acta Mol Basis Dis | Mitochondrial dysfunction in metabolic syndrome. | 2020 | Details |
| A07603 | 32427918 | Sci Rep | Hepatic steatosis among people living with HIV in Southern Brazil: prevalence and risk factors. | 2020 | Details |
| A07609 | 32424494 | Adv Exp Med Biol | Non-alcoholic Fatty Liver Disease and Diabetes Mellitus. | 2021 | Details |
| A07610 | 32423665 | Nutr Metab Cardiovasc Dis | Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy. | 2020 | Details |
| A07612 | 32422858 | Nutrients | A Diet Rich in Saturated Fat and Cholesterol Aggravates the Effect of Bacterial Lipopolysaccharide on Alveolar Bone Loss in a Rabbit Model of Periodontal Disease. | 2020 | Details |
| A07613 | 32420361 | Biomed Res Int | Catalpol Attenuates Hepatic Steatosis by Regulating Lipid Metabolism via AMP-Activated Protein Kinase Activation. | 2020 | Details |
| A07614 | 32420347 | Biomed Res Int | The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods. | 2020 | Details |
| A07615 | 32420328 | Biomed Res Int | Prevalence of Metabolic Syndrome and Nonalcoholic Fatty Liver Disease among Premenopausal and Postmenopausal Women in Ho Municipality: A Cross-Sectional Study. | 2020 | Details |
| A07616 | 32420071 | Transl Lung Cancer Res | Non-alcoholic fatty liver disease is associated with immune checkpoint inhibitor-based treatment response in patients with non-small cell lung cancer with liver metastases. | 2020 | Details |
| A07617 | 32419060 | Biochem Genet | Suppression of miR-30a-3p Attenuates Hepatic Steatosis in Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A07618 | 32418749 | Ann Hepatol | A Latin American survey on demographic aspects of hospitalized, decompensated cirrhotic patients and the resources for their management. | 2020 | Details |
| A07619 | 32417886 | J Infect Dis | Prevalence and Risk Factors of Moderate-to-Severe Hepatic Steatosis in Human Immunodeficiency Virus Infection: The Copenhagen Co-morbidity Liver Study. | 2020 | Details |
| A07620 | 32417373 | Life Sci | CREBH knockout accelerates hepatic fibrosis in mouse models of diet-induced nonalcoholic fatty liver disease. | 2020 | Details |
| A07621 | 32417256 | Biochim Biophys Acta Mol Cell Res | GSK-3 in liver diseases: Friend or foe? | 2020 | Details |
| A07622 | 32417163 | Chem Biol Interact | Potential role of gut microbiota, the proto-oncogene PIKE (Agap2) and cytochrome P450 CYP2W1 in promotion of liver cancer by alcoholic and nonalcoholic fatty liver disease and protection by dietary soy protein. | 2020 | Details |
| A07624 | 32416862 | Lancet Gastroenterol Hepatol | The effect of sleep on gastrointestinal functioning in common digestive diseases. | 2020 | Details |
| A07625 | 32416645 | Hepatology | Alanine Aminotransferase and Gamma-Glutamyl Transpeptidase Predict Histologic Improvement in Pediatric Nonalcoholic Steatohepatitis. | 2020 | Details |
| A07626 | 32415687 | Lipids | Relationships between Very Low-Density Lipoproteins-Ceramides, -Diacylglycerols, and -Triacylglycerols in Insulin-Resistant Men. | 2020 | Details |
| A07627 | 32414883 | CMAJ Open | Risk stratification of patients with nonalcoholic fatty liver disease using a case identification pathway in primary care: a cross-sectional study. | 2020 | Details |
| A07629 | 32414752 | BMJ Open Gastroenterol | Spatial expression of glucagon-like peptide 1 receptor and caveolin-1 in hepatocytes with macrovesicular steatosis in non-alcoholic steatohepatitis. | 2020 | Details |
| A07630 | 32414722 | Clin Med (Lond) | Decompensated cirrhosis is the commonest presentation for NAFLD patients undergoing liver transplant assessment. | 2020 | Details |
| A07631 | 32414691 | J Pharmacol Sci | Capsaicinoid nonivamide improves nonalcoholic fatty liver disease in rats fed a high-fat diet. | 2020 | Details |
| A07632 | 32414383 | Ann Clin Microbiol Antimicrob | Plasma CRP level is positively associated with the severity of COVID-19. | 2020 | Details |
| A07633 | 32413995 | Genes (Basel) | Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07634 | 32413869 | Aging (Albany NY) | Overexpression of miR-142-5p inhibits the progression of nonalcoholic steatohepatitis by targeting TSLP and inhibiting JAK-STAT signaling pathway. | 2020 | Details |
| A07636 | 32413340 | Lancet Gastroenterol Hepatol | Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. | 2020 | Details |
| A07637 | 32413192 | J Cell Physiol | Long noncoding RNA CCAT1 inhibits miR-613 to promote nonalcoholic fatty liver disease via increasing LXRα transcription. | 2020 | Details |
| A07638 | 32412768 | J Proteome Res | Glycopeptide Biomarkers in Serum Haptoglobin for Hepatocellular Carcinoma Detection in Patients with Nonalcoholic Steatohepatitis. | 2020 | Details |
| A07639 | 32411211 | Gastroenterol Res Pract | Nonalcoholic Fatty Liver Disease Is Associated with Helicobacter pylori Infection in North Urban Chinese: A Retrospective Study. | 2020 | Details |
| A07640 | 32411195 | Gastroenterol Res Pract | Mean Arterial Pressure Is Related to Incident Nonalcoholic Fatty Liver Disease among the Nonobese Female with Normal Low-Density Lipoprotein Cholesterol Levels: A Large Cohort Study in China. | 2020 | Details |
| A07641 | 32411189 | PPAR Res | Loss of Hepatocyte-Specific PPARγ Expression Ameliorates Early Events of Steatohepatitis in Mice Fed the Methionine and Choline-Deficient Diet. | 2020 | Details |
| A07642 | 32411096 | Front Endocrinol (Lausanne) | Macrophage Subsets in Obesity, Aligning the Liver and Adipose Tissue. | 2020 | Details |
| A07643 | 32410680 | Lipids Health Dis | Hepatic steatosis induced in C57BL/6 mice by a non-ß oxidizable fatty acid analogue is associated with reduced plasma kynurenine metabolites and a modified hepatic NAD+/NADH ratio. | 2020 | Details |
| A07644 | 32410559 | Curr Drug Metab | Evaluating Lean Liver Volume as a Potential Scaler for In Vitro-In Vivo Extrapolation of Drug Clearance in Obesity Using the Model Drug Antipyrine. | 2020 | Details |
| A07645 | 32410320 | Hepatol Res | Allele HLA-DQB1*06 reduces fibrosis score in patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A07646 | 32410310 | Liver Int | Objectively measured sedentary time, physical activity and liver enzyme elevations in US Hispanics/Latinos. | 2020 | Details |
| A07647 | 32410294 | J Cell Mol Med | Magnesium isoglycyrrhizinate prevents the nonalcoholic hepatic steatosis via regulating energy homeostasis. | 2020 | Details |
| A07648 | 32409850 | Internist (Berl) | [New pharmacological treatment options for nonalcoholic fatty liver disease]. | 2020 | Details |
| A07650 | 32409495 | Arch Dis Child | Non-alcoholic fatty liver disease and childhood obesity. | 2020 | Details |
| A07651 | 32408667 | Int J Environ Res Public Health | The Bisphenol A Induced Oxidative Stress in Non-Alcoholic Fatty Liver Disease Male Patients: A Clinical Strategy to Antagonize the Progression of the Disease. | 2020 | Details |